Neal Gordon, PhD
BDO USA
Managing Director in the BioProcess Technology Group
Neal is currently a Managing Director in the BioProcess Technology Group at BDO USA. Neal has over 30 years of experience in the Boston-area life science industry, and a hands-on?leader with a strong record of technology innovation and translation of platform technologies into products. As an accomplished biotech executive and entrepreneur, he has been involved with a variety of companies pioneering novel, first-in-class therapeutic strategies and analysis platforms. These experiences provided valuable background not only in translation of scientific platforms into specific products but importantly in development of manufacturing, product characterization and lot release paradigms that accommodate existing regulation. Neal is a subject matter expert in process and analytical development with significant exposure to the emerging fields of cell and gene therapy.
Prior to joining BDO, Neal was the Chief Development Officer at Cobalt Biomedicine, a company created by Flagship Pioneering that was acquired by Sana Biotechnology in 2018. Neal obtained a doctorate degree in biochemical engineering from the Massachusetts Institute of Technology and a bachelor’s degree in chemical engineering from McGill University.
Prior to joining BDO, Neal was the Chief Development Officer at Cobalt Biomedicine, a company created by Flagship Pioneering that was acquired by Sana Biotechnology in 2018. Neal obtained a doctorate degree in biochemical engineering from the Massachusetts Institute of Technology and a bachelor’s degree in chemical engineering from McGill University.